Adderley Green Surgery

Homepage

Opening Times

Please select a site

UPDATE

The Website is in the process of an update, please bear with us whilst this is done.

 

If you are unable to find what you need on here please contact the practice via Email: adderleygreen@stoke.nhs.uk

 

for any out of hours medical queries/emergencies please contact 111

Have Your Say

NHS Friends and Family

View results here

Error:
Error:
Error:
This form is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Keep up to date with the latest practice news

Newsletter

To receive future editions of the newsletter straight to your inbox sign up below.

This form is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Research Practice

Adderley Green Surgery works in partnership with the National Institute for Health and Care Research who fund, enable and deliver world-leading health and social care research that improves people's health and wellbeing, and promotes economic growth.

For more information on NIHR please visit: National Institute for Health and Care Research | NIHR

Our Current Research Projects:

WhAM Project

services

Weight Management

Weight-management services update – Mounjaro

We are receiving a significant number of enquiries about the availability of the Mounjaro weight-loss drug which has been approved by NHS England for eligible patients. NHS England has set the criteria for eligibility for the drug; this is a national policy which all NHS prescribers, such as GPs and pharmacists, are required to abide by. The criteria for weight management cannot be changed by prescribers.

Although NHS England has approved the drug, all GPs are waiting for information about how the drug will be provided to eligible patients, when, and for how long. We are also awaiting guidance about how the drug should be used by patients along with other services to support weight management, such as diet and exercise.

Current guidance is that anyone with a BMI of 40 or higher, and with four or more of the qualifying comorbidities (hypertension, dyslipidaemia, obstructive sleep apnoea, cardiovascular disease and type 2 diabetes) will be eligible for assessment to identify their suitability for Mounjaro. Anyone not meeting these criteria will not be eligible for assessment in the first year of the drug being available.

More information on local Weight Management services can be found on the ICS webpage please: Local Weight Management services - Staffordshire and Stoke-on-Trent, ICS